VectivBio : IRONWOOD PHARMACEUTICALS, INC - Form 6-K : vimarsana.com

IRONWOOD PHARMACEUTICALS, INC.


and


VECTIVBIO HOLDING AG


Dated as of May 21, 2023




TABLE... | May 23, 2023

Related Keywords

United States , Switzerland , Delaware , Bishopsgate , United Kingdom General , United Kingdom , London , City Of , California , Brazil , Basel Stadt , Boston , Massachusetts , New York , State Of Delaware , Brazilian , Swiss , Pricewaterhousecoopers Pw , Brandon Fenn , Ian Nussbaum , Scott Applebaum , Luca Santarelli , Daniele Rees , Claudia Daugusta , Andrew Clark , Charlesk Ruck , John Minardo , Michal Berkner , Tom Mccourt , Latham Watkins , Company Stock Options , None Of The Owned Company Intellectual Property , Company Board Recommendation , Company Material Adverse Effect , Stock Exchange Delisting , Company Board , Health Care , Exchange Act , Drug Administration , International Conference On Harmonization Guideline , Company Product , Company Restricted Share Purchase Agreements , Company Insurance , International Accounting Standards Board , Exchange Commission , Board Of Directors The Company , Ironwood Pharmaceuticals Gmb , Company Or Parent , Company Shareholder Meeting , Electronic Communications Amendments , Public Health Service , Exchange Act Of The , Company Articles , Kreos Capital Vi Expert Fund , No Third Party Beneficiaries , Award Or Company Restricted Share , Vectivbio Holding , Company Of The Transaction Agreement , Number Of Company , No Subsidiary Of The Company , Good Laboratory Practice , Electronic Communications Directive , Company To Parent , Government Services Administration System For Award Management , Company Plan Under Section , Company Disclosure Letter , Vectivbio Us Inc , Kreos Capital Vi United Kingdom , Company Of The , United States Federal Trade Commission , World Health Organization , Cooley United Kingdom , Service Provider , Service Providers , Nasdaq Stock Market , European Medicines Agency , Treatment Of Company Equity Award , Company Equity Award , No Presumption Against Drafting Party , Representative Of The Company , Revenue Service , Company Registered , Swiss Federal Tax Administration , Tcompany Equity , Company Intellectual Property Or Non , Deloitte , Employee Share Purchase Program , Governmental Authority , Company Stock Plan , Health Insurance Portability , Company Insurance Policies , Company Restricted Share Purchase Agreement , Company Stock , None Of The Company , Nasdaq , National Labor Relations Board , Course Of Business The Company , Services Providers , Party Beneficiaries , Affiliate Of The Company , United Nations , Company Permit Or Law , United States Department Of Justice , World Bank , Representatives Of The Company , Company Plan , Party Transactions , Company Shareholder Approval , Company Stock Options Or , Good Laboratory Practices , Company Shareholders , Neither The Company , Ironwood Pharmaceuticals Inc , International Monetary Fund , Neither The Company Board , Securities Exchange , Centers For Disease , European Union Or Her Majesty Treasury , Company Restricted , Company Stock Option Or , Health Care Program , Company Subsidiaries , Company Systems , Payment Fund , Company Restricted Share , Third Party Beneficiaries , Company Registered Intellectual Property , Company Equity Awards Or , International Financial Reporting Standards , Company Actions , Treatment Of Company Equity , Subsidiary Of The Company , Exchange Act The , Swiss Taxing Authority , Cantonal Tax Administration Of Basel Stadt , Company Of The Termination Fee , Company Intellectual Property , No Owned Company Intellectual Property , Compensation Committee Of The Company Board , Company Equity Awards , Vote Required , Financial Statements , Certain Changes , Regulatory Matters , Financial Advisor , Shareholder Approval Invitation , Shareholder Meeting , Governmental Approvals , Certain Matters , Exchange Delisting , Jury Trial , Support Agreement , Untrue Statements , Material Facts , Illegal Gratuities , Ironwood Pharmaceuticals , Ironwood Pharmaceuticals Gmbh , Merger Sub , Excluded Shares , Acceptance Time , Offer Price , Articles Amendment , Board Modification , Nasdaq Rules , Securities Exchange Act , Minimum Condition , Offer Condition , Antitrust Condition , Offer Conditions , Expiration Date , Nasdaq Global Market , Offer Documents , Recommendation Statement , Information Statement , Business Days , Compensation Committee , Swiss Law , Company Stock Option , Company Restricted Shares , Company Warrant , Company Warrants , Company Stock Plans , Internal Revenue Code , Paying Agent , Option Consideration , Warrant Consideration , Governmental Entity , Withholding Agent , Internal Revenue Service , Material Adverse Effect , Material Adverse , Annual Company Shareholder Approval , Existing Credit Agreements , Restricted Shares , Measurement Date , Stock Options , Existing Credit , All Company Equity Awards , Company Shareholder , Hart Scott Rodino Antitrust Improvements Act , Securities Act , Sarbanes Oxley Act , Regulations K , Annual Report , Ordinary Course , Governmental Entities , Restricted Share Purchase Agreement , Company Plans , United States Law , Each Company Plan , Fair Labor Standards Act , Worker Adjustment , Retraining Notification Act , Environmental Laws , Environmental Law , Leased Real Property , Hazardous Materials , Material Contracts , Tax Returns , Tax Return , Treasury Regulations Section , Treasury Regulation , United States Treasury Regulations Section , Current Report , Top Supplier , Each Material Contract , Material Contract , Company Insurance Policy , Intellectual Property , Non Owned Company Intellectual Property , Owned Company Intellectual Property , Permitted Liens , Company Intellectual , Subsidiarie Products , Healthcare Laws , Company Permits , Company Permit , Good Clinical Practice , Review Board , Good Manufacturing , Collaboration Partner , Corrupt Practices Act , Combating Bribery , Foreign Public Officials , International Business Transactions , United Kingdom Bribery Act , Anti Corruption Laws , Federal Health Care Program , Government Services Administration , Award Management , Federal Health Care Program Related , United States Department , Foreign Assets Control , Her Majesty , United States Governmental Entity , European Union , Processing Personal Information , Privacy Laws , Personal Information , All Personal Information , Updata Partners , Privacy Requirements , Privacy Policy , Data Partner , Processed Personal Information , Security Incidents , Security Incident , Personal Information Processed , Centerview Partners , Affiliate Transaction , Disclosure Letter , Parent Disclosure Letter , Parent Material Adverse , Nasdaq Global Select Market , Foreign Antitrust Laws , Shareholder Approval , Adverse Recommendation Change , Shareholder Approval Information , Legal Proceeding , Collaboration Partners , Antitrust Law , Annual Company Shareholder Meeting , Swiss Stamp Duties Act , Acquisition Proposal , Acquisition Transaction , Acceptable Confidentiality Agreement , Superior Proposal , Confidentiality Agreement , Alternative Acquisition Agreement , Business Day , Termination Fee , Regulationm A , Non Disclosure Agreement , Foreign Antitrust Law , Antitrust Laws , Counsel Only Material , Second Request , Non Required Remedy , Takeover Law , Continuing Employee , Continuing Employees , Existing Credit Agreement , Warrant Agreements , Pre Closing Holders , Swiss Tax , Swiss Tax Rulings , Swiss Tax Ruling , Swiss Taxing Authorities , Reserves Tax , Swiss Withholding Tax , Outside Date , Parent Material Adverse Effect , Entire Agreement , Governing Law , Specific Performance , Willful Breach , Reverse Termination Fee , Reimbursable Expenses , Wall Street Journal , Chief Legal Officer , Corporate Secretary , Swiss Official Gazette , Sherman Act , Clayton Antitrust Act , Federal Trade Commission Act , Commercial Register , Coronavirus Aid , Economic Security Act , Share Purchase Program , Restricted Share Purchase , Restricted Share Purchase Agreements , Incentive Plan , Company Shares , Disease Control , Employee Retirement Income Security Act , Term Loan Agreement , Kreos United Kingdom , Convertible Loan Agreement , Amendment Deed , United States Food , Federal Food , Cosmetic Act , Review Boards , International Conference , Anti Kickback Statute , False Claims Act , United States Code , Social Security Act , Medicare Prescription Drug , Modernization Act , Open Payments , Off The Shelf Software , Uniform Trade Secrets Act , Kreos Capital , Expert Fund , Owned Company Intellectual , Patent Cooperation Treaty , Treasury Regulation Section , Public Health Service Act , European General Data Protection Regulation , United Kingdom Data Protection Act , United Kingdom General Data Protection Regulation , Data Protection , Electronic Communications , Brazilian General Data Protection Law , Lei Geral De Prote , Accountability Act , Telephone Consumer Protection Act , Consumer Fraud , Abuse Prevention Act , Non Solicited Pornography , Marketing Act , Online Privacy Protection Act , California Consumer Privacy Act , California Privacy Rights Act , Swiss Code , Swiss Federal Act , Cantonal Tax Administration , Swiss Federal Tax Act , Withholding Tax , Stamp Duties , Warrant Agreement , Second Warrant Agreement , Hall Exhibits , Support Agreements , Presumption Against Drafting , Chief Executive Officer , Claudiad Augusta , Chief Financial Officer , Transaction Agreement , New Shares , Subject Shares , Each Stockholder , Such Stockholder , Subject Shares Transferred , Transfer Subject Shares , Agreement Until , Obligation Several , Vectivbio Holding Ag Stock Exchange , News , Nformation , Ress Release , Ironwood , Vectivbio , Olding , Ated , S , F , Ay Vect Ch1109007893 ,